AMAC in the Media

Phase 3 Clinical Trial of Investigational Vaccine for COVID-19 Begins

Posted on Tuesday, July 28, 2020
|
by
The Association of Mature American Citizens
|
3 Comments

vaccineA Phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19) in adults has begun. The vaccine, known as mRNA-1273, was co-developed by the Cambridge, Massachusetts-based biotechnology company Moderna, Inc., and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial, which will be conducted at U.S. clinical research sites, is expected to enroll approximately 30,000 adult volunteers who do not have COVID-19.

You can read more from the National Institutes of Health here.

Share this article:
Subscribe
Notify of
guest
3 Comments
Most Voted
Newest Oldest
Inline Feedbacks
View all comments
Bill Bryson
Bill Bryson
3 years ago

Be careful, I will “Not” take any d@mned vaccine for this BS.

Bill Bryson
Bill Bryson
3 years ago

Be careful, I will “Not” take any d@mned vaccine for this BS.

Join or Renew Today!

Save up to 25% by purchasing multi-year memberships! All Membership packages include your spouse for FREE!
5-Year Membership

$59.95

3-Year Membership

$42.00

1-Year Membership

$16.00

Lifetime Membership

$500.00

You can also print and mail your membership application. Download the application
3
0
Would love your thoughts, please comment.x
()
x